Description

The research activity of the Institute of Translational Pharmacology (IFT) is directed to study the onset mechanisms of human diseases, with particular reference to cancer, neurodegenerative disorders, infectious and inflammatory diseases. The mission of the Institute is devoted to develop innovative diagnostic and therapeutic strategies and transfer the results into clinical practice.
Specific expertises include: "drug discovery, design and delivery"; pharmacogenomics and regulatory aspects of drugs; study of therapeutic compounds and biotechnological tools to be used in regenerative medicine and in therapeutic field; study of innovative biomarkers for the diagnosis, prevention and treatment of the diseases, genotyping study and service for transplantation and degenerative diseases.